Skip to content

Biodexa Pharmaceuticals Plc

BDRX

CIK 0001643918 · Pharmaceutical Preparations · Nasdaq

  • Midatech Pharma Plc (until 2023-03-27)
← back to feed
Revenue (TTM)
£381K
−45.5% YoY FY Dec 2025
Net Income (TTM)
−£6.38M
−11.4% YoY FY Dec 2025
EPS Diluted (TTM)
−£0.00
+90.0% YoY FY Dec 2025
Gross Margin
1,751.2%
FY Dec 2025
Operating Margin
-2,269.0%
FY Dec 2025
Net Margin
-1,675.6%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
£8.53M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
225.82B sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings